Global Pharmacovigilance Market By Product Type (Chemotherapy, Contract Outsourcing) And By End-Users/Application (Pharma and Biotech Companies, Contract Research Organizations (CROs)) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

Abstract Global Pharmacovigilance Market is accounted for xx USD million in 2019 and is expected to reach xx USD million by 2026 growing at a CAGR of xx% during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global Pharmacovigilance market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. Pharmacovigilance Market report covers size, share and forecast (value and volume) by regions, top players, product types and applications, with historical data along with forecast from 2019 to 2026; The report covers an in depth description, competitive scenario, wide product portfolio of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis. By geography, this market has been segregated into five regions with revenue and growth rate of Pharmacovigilance from 2013 to 2026, • North America (U.S., Canada, Mexico) • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS) • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific) • Latin America (Brazil, Rest of L.A.) • Middle East And Africa(Turkey, GCC, Rest of Middle East) The major players operating into Pharmacovigilance Market include: Eli Lilly and Company ICON plc Elsevier Chiltern Atlantic Research Group Mapi Group Accenture Plc. Clinquest Group B.V. GSK PRA Health Sciences, Inc. This report segments the Global Pharmacovigilance Market as follows: Global Pharmacovigilance Market: Type Segment Analysis Chemotherapy Contract Outsourcing Global Pharmacovigilance Market: Application Segment Analysis Pharma and Biotech Companies Contract Research Organizations (CROs) Business Process Outsourcing (BPO) Firms Other Pharmacovigilance Service Providers There are 13 chapters to put on view for Pharmacovigilance Market: Chapter 1: Market Overview, Drivers, Restraints and Opportunities, Segmentation overview Chapter 2: Market competition by Manufacturers Chapter 3: Production by Regions Chapter 4: Consumption by Regions Chapter 5: Production, By Types, Revenue and Market share by Types Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications Chapter 7: Complete profiling and analysis of Manufacturers Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers Chapter 10: Marketing Strategy Analysis, Distributors/Traders Chapter 11: Market Effect Factors Analysis Chapter 12: Market Forecast Chapter 13: Pharmacovigilance Research Findings and Conclusion, Appendix, methodology and data source Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export have been determined using secondary sources and verified primary sources. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report. Industry Chain Analysis Raw Material and Suppliers Equipment and Suppliers Manufacturing Process Manufacturing Cost Structure Manufacturing Plants Distribution Analysis Available Customizations We can also provide customized report as per company's specific needs. We can also provide the customized separate regional or country-level reports, for the specific region as per client requirement.
Chapter 1 Industry Overview 1.1 Pharmacovigilance Market Overview 1.1.1 Pharmacovigilance Product Scope 1.1.2 Market Status and Outlook 1.2 Global Pharmacovigilance Market Size and Analysis by Regions (2014-2019) 1.2.1 North America Pharmacovigilance Market Status and Outlook 1.2.2 EU Pharmacovigilance Market Status and Outlook 1.2.3 Japan Pharmacovigilance Market Status and Outlook 1.2.4 China Pharmacovigilance Market Status and Outlook 1.2.5 India Pharmacovigilance Market Status and Outlook 1.2.6 Southeast Asia Pharmacovigilance Market Status and Outlook 1.3 Global Pharmacovigilance Market Segment by Types (2014-2025) 1.3.1 Global Pharmacovigilance Revenue and Growth Rate Comparison by Types (2014-2025) 1.3.2 Global Pharmacovigilance Revenue Market Share by Types in 2018 1.3.3 Chemotherapy 1.3.4 Contract Outsourcing 1.3.5 Type 3 Others 1.4 Pharmacovigilance Market by End Users/Application 1.4.1 Global Pharmacovigilance Revenue (USD Mn) Comparison by Applications (2014-2025) 1.4.1 Pharma and Biotech Companies 1.4.2 Contract Research Organizations (CROs) 1.4.3 Business Process Outsourcing (BPO) Firms Others Chapter 2 Global Pharmacovigilance Competition Analysis by Players 2.1 Global Pharmacovigilance Market Size (Million USD) by Players (2014-2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future Chapter 3 Company (Top Players) Profiles and Key Data 3.1 Eli Lilly and Company 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Eli Lilly and Company, Pharmacovigilance Revenue (Million USD) (2014-2019) 3.1.5 Recent Developments 3.2 ICON plc 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 ICON plc, Pharmacovigilance Revenue (Million USD) (2014-2019) 3.2.5 Recent Developments 3.3 Elsevier 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Elsevier, Pharmacovigilance Revenue (Million USD) (2014-2019) 3.3.5 Recent Developments 3.4 Chiltern 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Chiltern, Pharmacovigilance Revenue (Million USD) (2014-2019) 3.4.5 Recent Developments 3.5 Atlantic Research Group 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Atlantic Research Group, Pharmacovigilance Revenue (Million USD)(2014-2019) 3.5.5 Recent Developments 3.6 Mapi Group 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Mapi Group, Pharmacovigilance Revenue (Million USD)(2014-2019) 3.6.5 Recent Developments 3.7 Accenture Plc. 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Accenture Plc., Pharmacovigilance Revenue (Million USD)(2014-2019) 3.7.5 Recent Developments 3.8 Clinquest Group B.V. 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Clinquest Group B.V., Pharmacovigilance Revenue (Million USD) (2014-2019) 3.8.5 Recent Developments 3.9 GSK 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 GSK, Pharmacovigilance Revenue (Million USD) (2014-2019) 3.9.5 Recent Developments 3.10 PRA Health Sciences, Inc. 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 PRA Health Sciences, Inc., Pharmacovigilance Revenue (Million USD) (2014-2019) 3.10.5 Recent Developments Chapter 4 Global Pharmacovigilance Market Size Type (2014-2019) 4.1 Global Pharmacovigilance Market Size by Type (2014-2019) Chapter 5 Global Pharmacovigilance Market Size Application (2014-2019) 5.1 Global Pharmacovigilance Market Size by Application (2014-2019) 5.2 Potential Application of Pharmacovigilance in Future 5.3 Top Consumer / End Users of Pharmacovigilance Chapter 6 North America Pharmacovigilance Development Status and Outlook 6.1 North America Pharmacovigilance Market Size (2014-2019) 6.2 North America Pharmacovigilance Market Size by Application (2014-2019) Chapter 7 EU Pharmacovigilance Development Status and Outlook 7.1 EU Pharmacovigilance Market Size (2014-2019) 7.2 EU Pharmacovigilance Market Size by Application (2014-2019) Chapter 8 Japan Pharmacovigilance Development Status and Outlook 8.1 Japan Pharmacovigilance Market Size (2014-2019) 8.2 Japan Pharmacovigilance Market Size by Application (2014-2019) Chapter 9 China Pharmacovigilance Development Status and Outlook 9.1 China Pharmacovigilance Market Size and Forecast (2014-2019) 9.2 China Pharmacovigilance Market Size by Application (2014-2019) Chapter 10 India Pharmacovigilance Development Status and Outlook 10.1 India Pharmacovigilance Market Size and Forecast (2014-2019) 10.2 India Pharmacovigilance Market Size by Application (2014-2019) Chapter 11 Southeast Asia Pharmacovigilance Development Status and Outlook 11.1 Southeast Asia Pharmacovigilance Market Size and Forecast (2014-2019) 11.2 Southeast Asia Pharmacovigilance Market Size by Application (2014-2019) Chapter 12 Market Forecast by Regions and Application (2019-2025) 12.1 Global Pharmacovigilance Market Size (Million USD) by Regions (2019-2025) 12.1. North America Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.1.2 EU Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.1.3 China Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.1.4 Japan Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.1.5 Southeast Asia Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.1.6 India Pharmacovigilance Revenue and Growth Rate (2019-2025) 12.2 Global Pharmacovigilance Market Size by Application (2019-2025) Chapter 13 Pharmacovigilance Market Dynamics 13.1 Pharmacovigilance Market Opportunities 13.2 Pharmacovigilance Challenge and Risk 13.2.1 Competition from Opponents 13.2.2 Downside Risks of Economy 13.3 Pharmacovigilance Market Constraints and Threat 13.3.1 Threat from Substitute 13.3.2 Government Policy 13.3.3 Technology Risks 13.4 Pharmacovigilance Market Driving Force 13.4.1 Growing Demand from Emerging Markets 13.4.2 Potential Application Chapter 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs Trend/Customer Preference 14.3 External Environmental Change 14.3.1 Economic Fluctuations 14.3.2 Other Risk Factors Chapter 15 Research Finding /Conclusion Chapter 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer 16.4 Author List
1237

1656

OUR CLIENT